Skip to content

Studying the effectiveness of different Steroids in treatment of COVID-19

EVALUATING EFFECTIVENESS OF DEXAMETHASONE VS METHYLPREDNISOLONE IN MANAGEMENT OF COVID-19 INFECTION.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037112
Enrollment
399
Registered
2021-10-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: DEXAMETHASONE: 6MG OD, 6MGBD, 12MG OD Intervention2: NOT APPLICABLE: NOT APPLICABLE Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

Dr Sujith Vasireddy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)PCR confirmed COVID-19 infection 2)PaO2/FiO2 3)Positive pressure ventilation (non-invasive or invasive) or high flow nasal cannula (HFNC) higher than 45 L/min for less than 48 hours 4)Requiring ICU admission

Exclusion criteria

Exclusion criteria: 1)pregnancy; 2)Severe underlying disease, i.e. end stage of malignancy disease or end stage of pulmonary disease; 3)Underlying disease requiring corticosteroids; Contraindication for corticosteroids 4)Diseases causing an immunocompromised state, i.e AIDS.

Design outcomes

Primary

MeasureTime frame
ALL CAUSE MORTALITYTimepoint: Till discharge from the hospital

Secondary

MeasureTime frame
Cardiac complicationsTimepoint: After administration of steroid till discharge from the hospital;Development of ARDSTimepoint: After administration of steroid till discharge from the hospital;Length of hospital StayTimepoint: till discharge from the hospital;New requirement of ventilatory supportTimepoint: After administration of steroid till discharge from the hospital;Number of days of oxygen supportTimepoint: till discharge from the hospital;PneumoniaTimepoint: After administration of steroid till discharge from the hospital;Renal complicationsTimepoint: After administration of steroid till discharge from the hospital;SepsisTimepoint: After administration of steroid till discharge from the hospital;Steroid induced complicationTimepoint: After administration of steroid till discharge from the hospital;Transfer to ICUTimepoint: After administration of steroid till discharge from the hospital;Vascular ComplicationsTimepoint: After administration of steroid till discharge from the hospital

Countries

India

Contacts

Public ContactSujith Vasireddy

Kasturba Medical College, Manipal

shekar.uk@manipal.edu9148552033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026